-
Symbol
-
CMMB on Nasdaq
-
Investment type
-
Equity / Ordinary Shares / American Depositary Shares
-
Latest Disclosed Ownership
-
970K shares
-
Security Ownership
-
4.8%
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP ownership in Chemomab Therapeutics Ltd. Ordinary Shares / American Depositary Shares (CMMB)
2025-06-23 - ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 970K shares of Chemomab Therapeutics Ltd. Ordinary Shares / American Depositary Shares (CMMB).
This represents 4.8% percent ownership of the company.